Dedicated to the continuous improvement of health care, the Joint Commission works closely with medical providers as well as professionals in related fields such as pharmaceuticals to provide the highest quality care available. OncoMed Pharmaceutical Services is a proud member of the Joint Commission because of the organization’s rigorous standards and the ongoing dialogues promoting the Joint Commission among its membership. By maintaining strict accreditation requirements for organizations as well as stringent qualifications for individuals who wish to be certified by the organization, the Joint Commission strives to ensure best practices in all areas of health care.
Ellen Scharaga, a Senior Vice President at OncoMed, led the organization’s efforts to earn its Gold Seal from the Join Commission. It was important for OncoMed to gain this accreditation because it offers a solid platform for quality and safety while also allowing the company to foster its own internal improvements for the benefit of its customers. The advantages of abiding by the Joint Commission’s standards include improved protection for patients as well as reduction of mistakes that can be costly.
The tracer methodology recommended for pharmaceutical companies by the Joint Commission follows production from start to finish and includes standards for lab cleanliness and the manufacturing processes. The Joint Commission’s high level of professionalism creates a unique environment that encourages new ideas and guidelines to enhance the overall patient experience. Members are entitled to regular newsletters and email alerts that make them aware of new methods for bettering their processes as well access to a speakers’ bureau comprised of some of the most celebrated experts in their respective fields of health care.
Ellen Scharaga 